<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR13">
 <label>13.</label>
 <mixed-citation publication-type="other">Arzerra (ofatumumab) and Rituxan (rituximab): Drug safety warningâ€”New boxed warning, recommendations to decrease risk of hepatitis B reactivation. US Food and Drug Administration 2013.</mixed-citation>
</ref>
